Literature DB >> 23543057

Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions.

Athar Aziz1, E Joanna Baxter, Carol Edwards, Clara Yujing Cheong, Mitsuteru Ito, Anthony Bench, Rebecca Kelley, Yvonne Silber, Philip A Beer, Keefe Chng, Marilyn B Renfree, Kirsten McEwen, Dionne Gray, Jyoti Nangalia, Ghulam J Mufti, Eva Hellstrom-Lindberg, Jean-Jacques Kiladjian, Mary Frances McMullin, Peter J Campbell, Anne C Ferguson-Smith, Anthony R Green.   

Abstract

Large regions of recurrent genomic loss are common in cancers; however, with a few well-characterized exceptions, how they contribute to tumor pathogenesis remains largely obscure. Here we identified primate-restricted imprinting of a gene cluster on chromosome 20 in the region commonly deleted in chronic myeloid malignancies. We showed that a single heterozygous 20q deletion consistently resulted in the complete loss of expression of the imprinted genes L3MBTL1 and SGK2, indicative of a pathogenetic role for loss of the active paternally inherited locus. Concomitant loss of both L3MBTL1 and SGK2 dysregulated erythropoiesis and megakaryopoiesis, 2 lineages commonly affected in chronic myeloid malignancies, with distinct consequences in each lineage. We demonstrated that L3MBTL1 and SGK2 collaborated in the transcriptional regulation of MYC by influencing different aspects of chromatin structure. L3MBTL1 is known to regulate nucleosomal compaction, and we here showed that SGK2 inactivated BRG1, a key ATP-dependent helicase within the SWI/SNF complex that regulates nucleosomal positioning. These results demonstrate a link between an imprinted gene cluster and malignancy, reveal a new pathogenetic mechanism associated with acquired regions of genomic loss, and underline the complex molecular and cellular consequences of "simple" cancer-associated chromosome deletions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543057      PMCID: PMC3635733          DOI: 10.1172/JCI66113

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

Review 1.  Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders.

Authors:  F A Asimakopoulos; A R Green
Journal:  Br J Haematol       Date:  1996-11       Impact factor: 6.998

2.  Polymorphic and tissue-specific imprinting of the human Wilms tumor gene, WT1.

Authors:  K Nishiwaki; N Niikawa; M Ishikawa
Journal:  Jpn J Hum Genet       Date:  1997-03

3.  Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).

Authors:  A Brunet; J Park; H Tran; L S Hu; B A Hemmings; M E Greenberg
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  The Drosophila melanogaster tumor suppressor gene lethal(3)malignant brain tumor encodes a proline-rich protein with a novel zinc finger.

Authors:  J Wismar; T Löffler; N Habtemichael; O Vef; M Geissen; R Zirwes; W Altmeyer; H Sass; E Gateff
Journal:  Mech Dev       Date:  1995-09       Impact factor: 1.882

5.  Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins.

Authors:  Narendra Wajapeyee; Shu-Zong Wang; Ryan W Serra; Peter D Solomon; Arvindhan Nagarajan; Xiaochun Zhu; Michael R Green
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

6.  Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M.

Authors:  C Plass; H Shibata; I Kalcheva; L Mullins; N Kotelevtseva; J Mullins; R Kato; H Sasaki; S Hirotsune; Y Okazaki; W A Held; Y Hayashizaki; V M Chapman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

7.  Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.

Authors:  R Bookstein; P Rio; S A Madreperla; F Hong; C Allred; W E Grizzle; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

9.  Cooperative epigenetic modulation by cancer amplicon genes.

Authors:  Lixin Rui; N C Tolga Emre; Michael J Kruhlak; Hye-Jung Chung; Christian Steidl; Graham Slack; George W Wright; Georg Lenz; Vu N Ngo; Arthur L Shaffer; Weihong Xu; Hong Zhao; Yandan Yang; Laurence Lamy; R Eric Davis; Wenming Xiao; John Powell; David Maloney; Craig J Thomas; Peter Möller; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Kerry Savage; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Dennis D Weisenburger; Wing C Chan; Randy D Gascoyne; David Levens; Louis M Staudt
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

10.  Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.

Authors:  Ting Xi Liu; Michael W Becker; Jaroslav Jelinek; Wen-Shu Wu; Min Deng; Natallia Mikhalkevich; Karl Hsu; Clara D Bloomfield; Richard M Stone; Daniel J DeAngelo; Ilene A Galinsky; Jean-Pierre Issa; Michael F Clarke; A Thomas Look
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

View more
  14 in total

1.  Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.

Authors:  Mandy Brecqueville; Jérôme Rey; Raynier Devillier; Arnaud Guille; Rémi Gillet; José Adélaide; Véronique Gelsi-Boyer; Christine Arnoulet; Max Chaffanet; Marie-Joelle Mozziconacci; Norbert Vey; Daniel Birnbaum; Anne Murati
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

2.  Mosaic chromosome 20q deletions are more frequent in the aging population.

Authors:  Mitchell J Machiela; Weiyin Zhou; Neil Caporaso; Michael Dean; Susan M Gapstur; Lynn Goldin; Nathaniel Rothman; Victoria L Stevens; Meredith Yeager; Stephen J Chanock
Journal:  Blood Adv       Date:  2017-02-13

Review 3.  Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis.

Authors:  L Benetatos; G Vartholomatos
Journal:  Leukemia       Date:  2015-02-23       Impact factor: 11.528

4.  Deletion of Ptpn1 induces myeloproliferative neoplasm.

Authors:  F Jobe; B Patel; T Kuzmanovic; H Makishima; Y Yang; B Przychodzen; R E Hutchison; K K Bence; J P Maciejewski; G Mohi
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

5.  Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.

Authors:  Britta Höchsmann; Yoshiko Murakami; Makiko Osato; Alexej Knaus; Michi Kawamoto; Norimitsu Inoue; Tetsuya Hirata; Shogo Murata; Markus Anliker; Thomas Eggermann; Marten Jäger; Ricarda Floettmann; Alexander Höllein; Sho Murase; Yasutaka Ueda; Jun-Ichi Nishimura; Yuzuru Kanakura; Nobuo Kohara; Hubert Schrezenmeier; Peter M Krawitz; Taroh Kinoshita
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

6.  Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor.

Authors:  Fiona Poyer; Raúl Jimenez Heredia; Wolfgang Novak; Petra Zeitlhofer; Karin Nebral; Michael N Dworzak; Oskar A Haas; Kaan Boztug; Leo Kager
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

Review 7.  Epigenetics of myelodysplastic syndromes.

Authors:  R Itzykson; P Fenaux
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

8.  Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.

Authors:  Samuel A Stoner; Ming Yan; Katherine Tin Heng Liu; Kei-Ichiro Arimoto; Takahiro Shima; Huan-You Wang; Daniel T Johnson; Rafael Bejar; Catriona Jamieson; Kun-Liang Guan; Dong-Er Zhang
Journal:  Blood       Date:  2019-11-14       Impact factor: 25.476

9.  The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells.

Authors:  Fabiana Perna; Ly P Vu; Maria Themeli; Sonja Kriks; Ruben Hoya-Arias; Raya Khanin; Todd Hricik; Jorge Mansilla-Soto; Eirini P Papapetrou; Ross L Levine; Lorenz Studer; Michel Sadelain; Stephen D Nimer
Journal:  Stem Cell Reports       Date:  2015-03-05       Impact factor: 7.765

10.  Germline and somatic imprinting in the nonhuman primate highlights species differences in oocyte methylation.

Authors:  Clara Y Cheong; Keefe Chng; Shilen Ng; Siew Boom Chew; Louiza Chan; Anne C Ferguson-Smith
Journal:  Genome Res       Date:  2015-04-10       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.